Skip to the main content.
Facebook Linkedin X

CLD Rebate Program    

 

Get up to $500,000 toward your first GMP batch when moving from cell line development (CLD) to manufacturing.

Meet with our experts to discuss your molecules.

 

Schedule a Consultation
 

 

Sign Up for Limited Slots 

A Better Way from CLD to GMP 

Moving from cell line development to GMP is one of the most significant investments in biologics development. As milestones are reached, costs add up and financial flexibility narrows. The first GMP batch can feel stressful when the stake is the highest and momentum matter most.

The CLD Rebate Program helps eligible programs reduce financial pressure with up to $500,000 toward a first GMP batch while supporting a faster, more confident path to the clinic. The CLD Rebate Program reduces financial pressure at the pivotal transition point so you can focus on delivering your promise to patients.

200
+

Clinical Programs

450
+

INDs

(15+ Annual Supported)

14

Commercial Products

30
+

Years of Experience Bringing Therapeutics to Clinic

Unmatched Performance Meets Financial Efficiency

High Productivity

 

Up to 18 g/L for mAbs using proprietary mediaend up to $500k.

Short Timelines

 

As fast as 4 weeks to early formulated products and 9 weeks to RCB.

Reliable Stability

 

99% cell line stability across 60 generations.

How the CLD Rebate Program Works

 

Step 1: Develop your high-yielding cell line using Selexis technology.


Step 2: Advance into your first GMP batch with KBI. 


Step 3: Receive a credit of up to $500,000 applied to the proposal for
your first GMP batch.

Terms & Conditions 

  • The credit is applied directly to the proposal for your first GMP batch.
  • The credit matches the amount spent on CLD work, up to a maximum of $500,000.
  • The first GMP batch must use Selexis-derived cell line created during the CLD phase of the project.
  • Only applicable to new CLD programs. Cannot retroactively apply.
  • KBI reserves the right to end the CLD rebate program due to limited availability.

Connect With a CLD Specialist

Fill out the form below to connect with a CLD expert to discuss your program.

Flexible, Knowledgeable, and Proven


About KBI Biopharma

KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 1400+ customer partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian and microbial. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.

Science Driven. Customer Focused.